Correlation Between CytomX Therapeutics and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Mereo BioPharma Group, you can compare the effects of market volatilities on CytomX Therapeutics and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Mereo BioPharma.
Diversification Opportunities for CytomX Therapeutics and Mereo BioPharma
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between CytomX and Mereo is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Mereo BioPharma go up and down completely randomly.
Pair Corralation between CytomX Therapeutics and Mereo BioPharma
Given the investment horizon of 90 days CytomX Therapeutics is expected to generate 1.17 times more return on investment than Mereo BioPharma. However, CytomX Therapeutics is 1.17 times more volatile than Mereo BioPharma Group. It trades about -0.05 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.1 per unit of risk. If you would invest 109.00 in CytomX Therapeutics on November 8, 2024 and sell it today you would lose (22.00) from holding CytomX Therapeutics or give up 20.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
CytomX Therapeutics vs. Mereo BioPharma Group
Performance |
| Timeline |
| CytomX Therapeutics |
| Mereo BioPharma Group |
CytomX Therapeutics and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CytomX Therapeutics and Mereo BioPharma
The main advantage of trading using opposite CytomX Therapeutics and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| CytomX Therapeutics vs. Spero Therapeutics | CytomX Therapeutics vs. Instil Bio | CytomX Therapeutics vs. NextCure | CytomX Therapeutics vs. Assembly Biosciences |
| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |